Medical management and complications of X-linked hypophosphatemic vitamin D resistant rickets

Pediatrics International

Volumn 39, Issue 4, 1997, Pages 503-507

  Ono, Taeko ^a   Seino, Yoshiki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

24R; 25 dihydroxyvitamin D3; Growth hormone; Hyperparathyroidism; Nephrocalcinosis; X linked hypophosphatemia

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; ALKALINE PHOSPHATASE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CALCIUM; CREATININE; GROWTH HORMONE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D DERIVATIVE;

BONE BOWING; GROWTH CURVE; GROWTH DISORDER; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY CALCIFICATION; NONHUMAN; OSTEOTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; VITAMIN D RESISTANT RICKETS;

24,25-DIHYDROXYVITAMIN D 3; ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; DWARFISM; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA, FAMILIAL; INFANT; MALE; MICE; NEPHROCALCINOSIS; RICKETS;

EID: 0030867869     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03628.x     Document Type: Article

References (26)

1. Glorieux FH. Hypophosphatemic vitamin D-resistant rickets. In Favus MJ(ed.) Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 3rd edn. An Official Publication of The American Society for Bone and Mineral Reserch, New York, 1996; 316–19.
2. Tenenhouse HS et al. Effect of phosphonoformic acid, dietary and the Hyp mutation on kinetically distinct phosphate transport processes in mouse kidney. Biophys. Acta. 1989; 984: 207–13.
3. Nesbitt T. et al. Crosstransplantation of kidneys in normal and Hyp mice: Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J. Clin. Invest. 1992; 89: 1453–9.
4. Tenenhouse HS et al. Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets: Molecular characterization. J. Clin. Invest. 1994; 93: 671–6.
5. Meyer RA Jr et al. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. J. Bone Mineral Res. 1989; 4: 523–32.
6. The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemia rickets. Nat. Genet. 1995; 11: 130–6.
7. Du L. et al. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 1996; 36: 22–8.
8. Verge CF et al. Effect of therapy in X-linked hypophosphatemic rickets. N. Engl. J. Med. 1991; 325: 1843–8.
9. Reusz GS et al. X-linked hypophosphatemia: treatment, height gain and nephrocalcinosis. Arch. Dis. Child. 1990; 65: 1125–8.
10. Reusz GS et al. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis and phosphate treated hypophosphatemic rickets. Lancet 1990; 335: 1240–3.
11. Friedman NE et al. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 1993; 76: 839–44.
12. Wilson DM et al. Growth hormone therapy in hypophosphatemic rickets. Am. J. Dis. Child. 1991; 145: 1165–70.
13. Saggese G. et al. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: Effects on growth, mineral metabolism, and bone density. J. Pediatr. 1995; 127: 395–402.
14. 3. Endocrinology 1990; 127: 453–9.
15. 3 in the hypophosphatemic mouse. J. Bone Miner. Res. 1994; 9: 1967–74.
16. 3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Endocrinology 1996; 137: 2633–7.
17. 3 on bone. Am. J. Physiol. 1980; 238: E494–8.
18. 3. Cell Biol. Int. Rep. 1988; 12: 373–81.
19. Carpenter TO et al. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets: A clinical research center study. J. Clin. Endocrinol. Metab. 1996; 81: 2381–8.
20. Rubinovitch M. et al. Principles and results of corrective lower limbs osteotomies for patients with vitamin D-resistant hypophosphatemic rickets. Clin. Orthop. 1988; 237: 264–70.
21. Ferris B. et al. The orthopaedic management of hypophosphatemic rickets. J. Pediatr. Orthop. 1991; 11: 367–73.
22. Davies M. Hyperparathyroidism in X-linked hypophosphatemic osteomalacia. Clin. Endocrinol. 1995; 42: 205–6.
23. Reitz RE, Weinstein RL. Parathyroid hormone secretion in familial vitamin D resistant rickets. N. Engl. J. Med. 1973; 289: 941–5.
24. Carpenter TO et al. Nocturnal hyperparathyroidism: A frequent feature of X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 1994; 78: 1378–83.
25. Polisson RP et al. Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N. Engl. J. Med. 1985; 313: 313–16.
26. Hardy DC et al. X-linked hypophosphatemia in adults: Prevalence of skeletal radiographic and scintigraphic features. Radiology 1989; 171: 403–14.